Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Chongwen, China.
Acta Neurochir (Wien). 2012 May;154(5):855-61. doi: 10.1007/s00701-011-1259-z. Epub 2012 Jan 5.
Ganglioglioma is a common seizure-associated tumor, and some factors that may influence the postoperative seizure outcome have not been discussed or are controversial. The goal of this study was to observe the postoperative seizure outcome and the prognostic factors in patients with epileptogenic gangliogliomas.
In this retrospective study, 55 patients with epileptogenic gangliogliomas underwent surgery. Postoperative seizure outcome during follow-up was recorded, and possible postoperative prognostic factors were analyzed.
There were 30 males and 25 females in our study. Twenty patients presented with chronic seizures. The mean age at surgery was 19.39 years, and the mean seizure duration prior to surgery was 4.47 years. Forty-three patients had complex partial seizures, 12 patients had simple partial seizures, and secondary generalization occurred in 18 patients. Brain magnetic resonance imaging (MRI) revealed 32 tumors were located in the temporal lobe and 23 in the extratemporal lobes. Intraoperative electrocorticography (ECoG) and intraoperative ultrasound (IOUS) were used in 42 and 11 patients, respectively. Gross total resection of the tumor was achieved in 42 patients (1 patient underwent reoperation), subtotal resection in 11, and partial resection in 2. Simple lesionectomy and tailored epilepsy surgery were performed in 24 and 31 patients, respectively. After a mean follow-up of 3.27 years, 48 patients, including 1 re-operated patient, were seizure free (Engel class I). None of the factors, including age at surgery, seizure duration prior to surgery, the type of seizures, use of intraoperative ECoG and IOUS, extent of tumor resection, and surgical strategy, proved to be significantly correlated with postoperative seizure outcome.
Surgical treatment is effective and safe for patients with epileptogenic gangliogliomas. Early surgical intervention is necessary for achieving early seizure control. Neither intraoperative ECoG nor IOUS necessarily leads to better seizure control, although the latter can be helpful in achieving complete tumor resection. Simple lesionectomy is sufficient for favorable postoperative seizure outcome.
神经节神经胶质瘤是一种常见的与癫痫相关的肿瘤,一些可能影响术后癫痫发作结果的因素尚未得到讨论或存在争议。本研究的目的是观察致痫性神经节神经胶质瘤患者的术后癫痫发作结果和预后因素。
在这项回顾性研究中,55 例致痫性神经节神经胶质瘤患者接受了手术。记录了随访期间的术后癫痫发作结果,并分析了可能的术后预后因素。
研究中,男性 30 例,女性 25 例。20 例患者表现为慢性癫痫发作。手术时的平均年龄为 19.39 岁,术前癫痫发作持续时间平均为 4.47 年。43 例患者为复杂部分性发作,12 例患者为单纯部分性发作,18 例患者继发全身性发作。脑磁共振成像(MRI)显示 32 例肿瘤位于颞叶,23 例位于颞叶外。42 例患者术中使用皮质脑电图(ECoG),11 例患者术中使用术中超声(IOUS)。42 例患者实现肿瘤全切除(1 例患者再次手术),11 例患者实现次全切除,2 例患者实现部分切除。24 例患者行单纯病变切除术,31 例患者行个体化癫痫手术。平均随访 3.27 年后,48 例患者(包括 1 例再次手术患者)癫痫无发作(Engel 分级 I)。手术时的年龄、术前癫痫发作持续时间、癫痫发作类型、术中 ECoG 和 IOUS 的使用、肿瘤切除程度和手术策略等因素均与术后癫痫发作结果无显著相关性。
手术治疗对致痫性神经节神经胶质瘤患者有效且安全。早期手术干预对于实现早期癫痫控制是必要的。尽管术中 IOUS 有助于实现肿瘤全切,但术中 ECoG 和 IOUS 并不一定能更好地控制癫痫发作。单纯病变切除术对于术后良好的癫痫发作结果是足够的。